What's Happening?
Ronovo Surgical, a Shanghai-based company, has successfully closed its Series D financing round, securing a total investment of $67 million. This funding round was led by Johnson & Johnson's corporate venture capital organization, JJDC. The investment adds to Ronovo's previous Series C and Series B rounds, bringing its total funding to over $100 million in 2025. Alongside the financing, Ronovo has entered into a collaboration agreement with Johnson & Johnson to advance the commercialization of its Carina modular robotic surgery platform in China. The Carina system, unveiled in February 2023, is designed to provide configurable robotic assistance for laparoscopic surgeries across multiple specialties. It has received approval from China's National Medical Products Administration, marking it as the first modular surgical robotic system in the country to cover four major specialties. Ronovo is also pursuing global expansion efforts, with submissions underway in Europe and South America.
Why It's Important?
The investment and partnership with Johnson & Johnson represent significant steps for Ronovo Surgical in expanding its presence in the surgical robotics market. The Carina platform addresses key challenges in minimally invasive surgeries, offering surgeons flexibility in instrument choice and anatomical access. This development is poised to enhance surgical outcomes and efficiency, potentially benefiting healthcare providers and patients. The collaboration with Johnson & Johnson could accelerate Ronovo's commercial momentum in China and lay the groundwork for international growth. As the demand for advanced surgical technologies increases, Ronovo's expansion efforts may contribute to the broader adoption of robotic surgery, impacting the healthcare industry globally.
What's Next?
Ronovo Surgical plans to continue its global expansion efforts, with submissions for regulatory approval underway in Europe and South America. The collaboration with Johnson & Johnson is expected to further accelerate the commercialization of the Carina platform in China. As Ronovo pursues international growth, it may face challenges related to regulatory approvals and market competition. The company's ability to navigate these challenges and successfully expand its market presence will be crucial for its long-term success.
